Regeneron Pharmaceuticals
REGN
#296
Rank
โ‚น7.320 T
Marketcap
โ‚น69,068
Share price
1.50%
Change (1 day)
20.18%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น446.36 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.24 Billion. In 2024 the company made an earning of โ‚น438.66 Billion, an increase over its 2023 earnings that were of โ‚น385.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น446.36 B1.76%
2024 โ‚น438.66 B13.83%
2023 โ‚น385.38 B-13.57%
2022 โ‚น445.90 B-47.9%
2021 โ‚น855.85 B144.75%
2020 โ‚น349.69 B56.86%
2019 โ‚น222.92 B-4.87%
2018 โ‚น234.34 B22.86%
2017 โ‚น190.75 B56.3%
2016 โ‚น122.04 B8.55%
2015 โ‚น112.43 B54.53%
2014 โ‚น72.75 B11.14%
2013 โ‚น65.46 B72.13%
2012 โ‚น38.03 B-285.93%
2011 -โ‚น20.46 Billion121.73%
2010 -โ‚น9.23 Billion37.18%
2009 -โ‚น6.73 Billion-14.6%
2008 -โ‚น7.88 Billion-25.02%
2007 -โ‚น10.51 Billion6.32%
2006 -โ‚น9.88 Billion-186.52%
2005 โ‚น11.41 B2103.7%
2004 โ‚น0.51 B-105.66%
2003 -โ‚น9.16 Billion-18.18%
2002 -โ‚น11.2 Billion42.33%
2001 -โ‚น7.87 Billion129.35%
2000 -โ‚น3.43 Billion51.87%
1999 -โ‚น2.26 Billion92.19%
1998 -โ‚น1.18 Billion66.23%
1997 -โ‚น0.71 Billion-55.49%
1996 -โ‚น1.59 Billion103.53%
1995 -โ‚น0.79 Billion-70.89%
1994 -โ‚น2.68 Billion-26.08%
1993 -โ‚น3.63 Billion114.67%
1992 -โ‚น1.69 Billion196.77%
1991 -โ‚น0.57 Billion87.88%
1990 -โ‚น0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.973 T 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.506 T 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น756.57 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น835.15 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น174.73 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.95 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA